Ever since the draft of the human genome became available in 2001, there has been a nagging question about the genome’s “dark matter”—the parts of the map that were ...
Noyo, the leading API platform powering frictionless benefits, today announced that it has closed $45M in Series B financing. Norwest Venture Partners led the round, joined by Workday Ventures, ...
Concert Health, a leading behavioral health medical group, today announced the closing of its $42M Series B financing, led by Define Ventures with participation from existing investors Healthy Ventures, ...
For more than a year, Victoria Gray's life had been transformed. Gone were the sudden attacks of horrible pain that had tortured her all her life. Gone was the ...
As Vasanthi Viswanathan was wrapping up her postdoc in chemical biologist Stuart Schreiber’s lab at Broad Institute of MIT and Harvard, she found herself at a crossroads. Viswanathan had ...
Scientists are a cautious bunch, fond of a caveat even when describing their own research. “Our favourite expressions are ‘Yes, but…’ and ‘On the other hand…’ and ‘It remains ...
CRISPR is the latest and most powerful technique for changing the genetic code of living things. This method of gene editing is already showing great promise in treating people ...
Gene editing has become one of biotech's hottest areas as the first-in-human results have suggested the technology holds the potential to cure certain diseases with a single treatment.
In 2021, ...
Scientists have discovered DNA sequences in wetland soil that are unlike anything ever found and which could have “important and unanticipated climate implications,” according to a new preprint study co-authored by ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
Patrick Doherty had always been very active. He trekked the Himalayas and hiked trails in Spain.
But about a year and a half ago, he noticed pins and needles in ...
The gene editor CRISPR excels at fixing disease mutations in lab-grown cells. But using CRISPR to treat most people with genetic disorders requires clearing an enormous hurdle: getting the ...
Proteins are the building blocks of the human body and have many critical roles. Since proteins are involved in multiple biological functions, they also play an important role in ...
Digital data related to Nobel Prize-winning inventions for gene editing and cancer immunotherapy will be sold connected to non-fungible tokens next week, a novel way for the University of ...
Developing therapeutics is difficult—developing neurotherapeutics is even harder. The blood-brain barrier protecting the brain from unwanted substances makes it extremely difficult for neurotherapeutics to reach their target.
Herophilus, a San ...
How much will someone be willing to pay for a few pages of quarter-century-old bureaucratic university paperwork that have been turned into a blockchain-encoded piece of digital art?
Berkeley announced ...
Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, has appointed Sharath Hegde, Ph.D. as the company’s new Chief Scientific Officer. Dr. Hegde brings over 30 ...
Tory Burch has helped thousands of women entrepreneurs through her eponymous foundation and its education programs, but very few recipients of her coveted one-year business fellowship have founded biotech ...
Fireside chats have become a staple of pandemic-era virtual events. The reasons are clear: they offer a glimpse into an otherwise private conversation and it’s entertaining to listen to ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
In this latest "Bloomberg Studio 1.0," host Emily Chang sits down with CRISPR co-inventor and 2020 Nobel Prize winner, Dr. Jennifer Doudna. They discuss her groundbreaking work on DNA, ...
Nearly a decade ago, when the first CRISPR companies started looking for capital, Behzad Aghazadeh passed.
Aghazadeh, one of biotech’s more opinionated investors, had invested in gene editing before, but ...
The pandemic year has been marked by so much tragedy, but I am heartened by what scientific innovation and collaboration have achieved to help move our society forward.
Last March, ...
When Jennifer Doudna won the Nobel Prize for Chemistry last year, there was no black-tie ceremony in Sweden. Because of the pandemic, she picked up the medal in her backyard.
Correspondent ...
When last year’s Nobel prize for chemistry was awarded to biochemist Jennifer Doudna and microbiologist Emmanuelle Charpentier for their work in developing the technique of gene editing known as Crispr-Cas9 ...
In the spring of 2014, Jennifer Doudna had a nightmare.
The Berkeley biochemist had helped to invent a powerful new technology that made it possible to edit the human genome—an ...
In The Code Breaker, Walter Isaacson recounts the drama of the discovery in a digestible narrative that tackles the promise and the peril of Crispr.
For Isaacson, an accomplished storyteller of ...
Where do you take your career after you’ve won all of science’s biggest prizes? In this episode of Stereo Chemistry, C&EN executive editor Lisa Jarvis sits down with Nobel ...
Concert Health, a leading behavioral health medical group, today announced the closing of its Series A funding round at $14 million led by Vertical Venture Partners with participation from ...
The response to Covid-19 has been momentous but discoveries in AI, diet, conservation, space and beyond, show the power of science to improve the world post-pandemic
Genome-editing technology
This year finally ...
In February, Jennifer Doudna, one of America’s most prominent scientists, was still focused on CRISPR—the gene-editing tool that she’d co-discovered and that won her a Nobel Prize in October. But ...
TechCrunch has covered Noyo a few times in the last year. The startup builds APIs for the insurance market, a bit like what Plaid set out to do for ...
2020 Chemistry Nobel laureate Jennifer Doudna joins Fareed for a primer on CRISPR, a technology that allows for precise gene editing.
https://twitter.com/FareedZakaria/status/1333130472902234112
Focus
CRISPR
Client
UC Berkeley / IGI
WATCH THE ...
When Jennifer Doudna woke up, she realised her phone had been buzzing on and off for some time. It was still dark outside. In fact, her phone told her ...
CommonSpirit Health, a national nonprofit health system serving communities at more than 1,000 care sites and 137 hospitals across 21 states, today announced it is offering new access to ...
A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Doudna’s UC Berkeley genetics lab (alongside Doudna herself) launched on Tuesday, debuting a platform designed ...
Three years ago, Jennifer Doudna gathered with two postdocs and a fellow biochemist around a circular table on the second floor of UC Berkeley’s Energy Biosciences building, where they ...
The new coronavirus can leave some patients with signs of heart inflammation and injury months after they get sick with Covid-19, even in cases where their illness wasn’t severe, ...
Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to ...
From the images of cloudy chest scans and gasping patients hooked up to ventilators, we’ve been conditioned to think of Covid-19 as a respiratory disease. But it’s not just about the lungs.
Even from ...
Maybe we should think of Covid-19 as a heart disease.
When SARS-CoV-2 virus was added to human heart cells grown in lab dishes, the long muscle fibers that keep hearts ...
Nearly two years after the birth of the first “CRISPR babies” stunned the world, an international group of experts on Thursday warned such human experimentation — in which the DNA ...
It’s still too soon to try to make genetically edited babies because the science isn’t advanced enough to ensure safety, says an international panel of experts who also mapped ...
These tiny, ancient predators do more than cause pandemics.
Host Kenneth Cukier and science editor Geoff Carr investigate how viruses have shaped the world. Evolutionary biologist David Enard explains how ...
The coronavirus pandemic is accelerating the development of CRISPR-based tests for detecting disease — and highlighting how gene-editing tools might one day fight pandemics, one of its discoverers, Jennifer ...
Ask any expectant couple what they hope their baby will be, and one answer is likely to be “healthy.”
But one gene gone awry can imperil a child’s health, causing ...
A new Innovative Genomics Institute study is underway at the University of California, Berkeley to find out whether a saliva test can detect and identify asymptomatic carriers of the ...
With the start of school fast approaching, colleges and universities across the U.S. are rushing to rejigger the higher-education experience for the coronavirus era. Many are seeking ways to ...
Scientists from the University of California, Berkeley, have begun trials of a new spit test for COVID-19 infections developed by the university’s Innovative Genomics Institute.
Since the disease was first ...
California is experiencing a surge in reported cases of COVID-19. Three months into the pandemic tests remain scarce.
Early on, at UC Berkeley, Dr. Jennifer Doudna who co-discovered CRISPR gene editing ...
I have always loved mystery stories. Maybe that explains my fascination with science, which is humanity’s attempt to understand the longest-running mystery we know: the origin and function of ...
Exploring the COVID-19 crisis and the way forward.
Treating a disease that affects people of all ages and health backgrounds in different ways is no simple feat. ABC News’ Diane ...
When a stay-at-home order in March all but closed the revered labs of the gene-editing pioneer Jennifer Doudna, her team at the University of California, Berkeley dropped everything and started testing ...
In his 20 years in and out of homelessness, Ollie Harris, 69, has seen a lot of things. But what happened on a recent Friday was new.
Sitting outside his ...
Increasingly inexpensive genetic sequencing and engineering tools could upend everything from health care to fuel.
Why it matters: This bio revolution could lead to a world that is more sustainable and ...
Clinical trials of genome-editing agents — including CRISPR–Cas9 editors, zinc finger nucleases and TALENs — are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.
Focus
CRISPR
Client
UC Berkeley
READ THE ...
As the new coronavirus has spread from person to person, and country to country, the virus has changed thousands of times. The vast majority of these changes are incremental. ...
